Yet, the major limitation of this study was, beside the small cohort size, that the standard of reference was inadequate due to the lack of MDM2 amplification status assessment or the assessment of other cytogenetic markers [21], and thus, several actual ALTs may have been falsely classified as lipomas. This evidence concerns the gene MDM2 and lipoma.